.ANALYSIS EMPHASIZE.16 October 2024.
In the NIAGARA litigation, the add-on of perioperative durvalumab to common procedure for muscle-invasive bladder cancer enhanced event-free and also generally survival, noting a brand new treatment alternative for this health condition.